Yoshiro Saito

10.3k citations

257 papers · 6.5k indexed · h-index 45

Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism 68
- Drug-Induced Adverse Reactions 25
Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 68
- Drug-Induced Adverse Reactions 25
Oncology top 1%
- Drug Transport and Resistance Mechanisms 43
Pediatrics, Perinatology and Child Health top 1%
Toxicology top 1%
Immunology
- Biosimilars and Bioanalytical Methods 23
Molecular Biology
- Cancer therapeutics and mechanisms 19
- Metabolomics and Mass Spectrometry Studies 14
Computational Theory and Mathematics
- Computational Drug Discovery Methods 17
Biochemistry
- Eicosanoids and Hypertension Pharmacology 14

Co-authors: Jun‐ichi Sawada Shogo Ozawa Nahoko Kaniwa Keiko Maekawa Kouichi Kurose Kimie Sai Emiko Sugiyama Mayumi Saeki
Cited by: Pharmacology Oncology
Journals: Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (4 papers)Blood (1 paper)
Partner nations: Japan United States China

In The Last Decade

Yoshiro Saito

241 papers receiving 6.4k citations

Peers

Countries citing papers authored by Yoshiro Saito

Since Specialization

Citations

This map shows the geographic impact of Yoshiro Saito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiro Saito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiro Saito more than expected).

Fields of papers citing papers by Yoshiro Saito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiro Saito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiro Saito. The network helps show where Yoshiro Saito may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yoshiro Saito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yoshiro Saito Line = papers co-authored together Yoshiro Saito links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Current status of Imaging Mass Spectrometry in drug discovery and development: A survey highlighting technical challenges and future directions Drug Metabolism and Pharmacokinetics ·Yukari Tanaka,Hiroyuki Yokoi,Hidefumi Kaji,Yoko Urasaki,Masanobu Nishidate,Shin-ichiro Nitta,Kenichi Watanabe,Tomomi Ishida,Kouji Tanaka,Rika Komatsu,Kenji Yoshida,Kosuke Saito,Yoshiro Saito,Hiroshi Yamazaki	2025	1
2	Clinical characteristics of drug-induced interstitial pneumonia in Japan Respiratory Investigation ·Miwa Yamanaka,Atsuhito Ushiki,Koichiro Tatsumi,Akihiko Gemma,Noboru Hattori,Yoïchi Tanaka,Yoshiro Saito,Masayuki Hanaoka	2025	1
3	Higher-order structure comparison of the reference and biosimilar products using spectral distance calculation on the circular dichroism spectra Journal of Pharmaceutical Sciences ·Hiroko Shibata,Taiji Oyama,Masato Kiyoshi,Satoko Suzuki,Yuji Higuchi,Yoshiro Saito,Akiko Ishii‐Watabe	2025	1
4	Japan's Perspective on Facilitating Drug Development Through Asian Cooperation in Multi‐Regional Clinical Trials: Insights From Regulatory Research Clinical and Translational Science ·Masahiro Tohkin,Yoshiro Saito,Yoshiaki Uyama	2025	1
5	Evaluation of anti-drug antibodies against therapeutic monoclonal antibodies and related product in Japanese patients with rheumatoid arthritis and their clinical impact European Journal of Pharmaceutical Sciences ·Hiroko Shibata,Kazuko Nishimura,Eri Tsukagoshi,Akiko Ishii‐Watabe,Yoshiro Saito,Soichi Yamada,Shotaro Masuoka,Wataru Hirose,Shinichi Kawai,Toshihiro Nanki	2025	0
6	Plasma and Hepatic Exposures of Celecoxib and Diclofenac Prescribed Alone in Patients with Cytochrome <i>P450 2C93</i> Modeled after Virtual Oral Administrations and Likely Associated with Adverse Drug Events Reported in a Japanese Database Biological and Pharmaceutical Bulletin* ·Koichiro Adachi,Katsuhiro Ohyama,Yoïchi Tanaka,Hina Nakano,Tasuku Sato,Norie Murayama,Makiko Shimizu,Yoshiro Saito,Hiroshi Yamazaki	2023	8
7	Significant association between HLA‐B35:01* and onset of drug‐induced liver injury caused by Kampo medicines in Japanese patients Hepatology Research ·Ryosuke Nakamura,Noriaki Arakawa,Yoïchi Tanaka,Nahoko Uchiyama,Akihiro Sekine,Yoichi Mashimo,Keiji Tsuji,Tatehiro Kagawa,Ken Sato,Masaaki Watanabe,Mitsuhiko Aiso,Yoichi Hiasa,Yoshiyuki Takei,Hiromasa Ohira,Minoru Ayada,Eri Tsukagoshi,Keiko Maekawa,Masahiro Tohkin,Yoshiro Saito,Hajime Takikawa	2022	5
8	Frequency of null genotypes of glutathione S‐transferase M1 and T1 in Japanese patients with drug‐induced liver injury Hepatology Research ·Kazuya Maeda,Hajime Takikawa,Mitsuhiko Aiso,Kenji Tsuji,Tatehiro Kagawa,Masaaki Watanabe,Ken Sato,Shotaro Sakisaka,Yoichi Hiasa,Yoshiyuki Takei,Hiromasa Ohira,Etsuko Hashimoto,Minoru Ayada,Tadashi Ikegami,Noriaki Arakawa,Hiroyuki Kusuhara,Yoshiro Saito,Yuichi Sugiyama	2022	3
9	Matrix-Assisted Laser Desorption and Ionization Time-of-Flight Mass Spectrometry Analysis for the Direct Detection of SARS-CoV-2 in Nasopharyngeal Swabs Analytical Chemistry ·Tomoya Yoshinari,Katsuhiko Hayashi,Shouhei Hirose,Kenji Ohya,Takahiro Ohnishi,Maiko Watanabe,Satoshi Taharaguchi,Hirohisa Mekata,Takahide Taniguchi,Takuya Maeda,Yuta Orihara,Rieko Kawamura,Sakura Arai,Yoshiro Saito,Yukihiro Goda,Yukiko Hara‐Kudo	2022	11
10	High hepatic and plasma exposures of atorvastatin in subjects harboring impaired cytochrome P450 3A4∗16 modeled after virtual administrations and possibly associated with statin intolerance found in the Japanese adverse drug event report database Drug Metabolism and Pharmacokinetics ·Koichiro Adachi,Katsuhiro Ohyama,Yoïchi Tanaka,Tasuku Sato,Norie Murayama,Makiko Shimizu,Yoshiro Saito,Hiroshi Yamazaki	2022	13
11	Imaging Mass Spectrometry (IMS) for drug discovery and development survey: Results on methods, applications and regulatory compliance Drug Metabolism and Pharmacokinetics ·Eric Solon,M. Reid Groseclose,Stacy Ho,Kouji Tanaka,Naoyuki Nakada,Stefan Linehan,Masanobu Nishidate,Hiroyuki Yokoi,Hidefumi Kaji,Yoko Urasaki,Kenichi Watanabe,T. Ishida,Rika Komatsu,Kenji Yoshida,Hiroshi Yamazaki,Kosuke Saito,Yoshiro Saito,Yukari Tanaka	2021	4
12	Association of HLA-DRB104:05 allele with drug-induced interstitial lung disease in Japanese population The Pharmacogenomics Journal* ·Takuya Imatoh,Atsuhito Ushiki,Masao Ôta,Michiko Ito,Akihiro Sekine,Taiki Yamashita,Yoichi Mashimo,Ryosuke Nakamura,Kosuke Saito,Yoshiro Saito,Masayuki Hanaoka	2020	12
13	Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myeloma Cancer Science ·Keiko Maekawa,Masaki Ri,Miki Nakajima,Akihiro Sekine,Ryuzo Ueda,Masahiro Tohkin,Naoki Miyata,Yoshiro Saito,Shinsuke Iida	2019	18
14	Lipid profiling of pre-treatment plasma reveals biomarker candidates associated with response rates and hand–foot skin reactions in sorafenib-treated patients Cancer Chemotherapy and Pharmacology ·Kosuke Saito,Masafumi Ikeda,Yasushi Kojima,Hiroko Hosoi,Yoshiro Saito,Shunsuke Kondo	2018	19
15	<b>Influences of Long-Term, High-Dose Acetaminophen Administration on Liver Function Markers in Healthy Japanese Adults </b> Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Ildae Song,Rieko Tanaka,Masako Aso,Yasutoshi Sakamoto,Mika Maeda,Michiru OCHIAI,Yoshiro Saito,Keiko Maekawa,Yuji Kumagai	2017	1
16	Lack of ethnic differences of moxifloxacin and metabolite pharmacokinetics in East Asian men Journal of Pharmacokinetics and Pharmacodynamics ·Motohide Kaneko,Takahiko Aoyama,Y. Ishida,Atsushi Miyamoto,Yoshiro Saito,Masahiro Tohkin,Shinichi Kawai,Yoshiaki Matsumoto	2017	6
17	Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer’s disease Lipids in Health and Disease ·Yoko Tajima,Masaki Ishikawa,Keiko Maekawa,Mayumi Murayama,Yuya Senoo,Tomoko Nishimaki‐Mogami,Hiroki Nakanishi,Kazutaka Ikeda,Makoto Arita,Ryo Taguchi,Alato Okuno,Ryuta Mikawa,Shumpei Niida,Osamu Takikawa,Yoshiro Saito	2013	116
18	[Trends in drug-induced liver injury based on reports of adverse reactions to PMDA in Japan]. PubMed ·Chie Sudo,Keiko Maekawa,Katsunori Segawa,Tadaaki Hanatani,Kimie Sai,Yoshiro Saito	2012	2
19	Twelve Novel Single Nucleotide Polymorphisms in the CES2 Gene Encoding Human Carboxylesterase 2 (hCE2) Drug Metabolism and Pharmacokinetics ·SuRyang Kim,Takahiro Nakamura,Yoshiro Saito,Kimie Sai,Toshiharu Nakajima,Hirohisa Saito,Kuniaki Shirao,Hironobu Minami,Atsushi Ohtsu,Teruhiko Yoshida,Nagahiro Saijo,Shogo Ozawa,Jun‐ichi Sawada	2003	16
20	Three-Dimensional Transport Calculation Method for Eigenvalue Problems Using Diffusion Synthetic Acceleration Journal of Nuclear Science and Technology ·Masaru BANDO,Toshihisa Yamamoto,Yoshiro Saito,Toshikazu Takeda	1985	19

About Yoshiro Saito

Yoshiro Saito is a scholar working on Pharmacology, Biochemistry and Oncology, having authored 257 papers that have together received 6.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (68 papers), Drug Transport and Resistance Mechanisms (43 papers), Drug-Induced Adverse Reactions (25 papers), Biosimilars and Bioanalytical Methods (23 papers), Cancer therapeutics and mechanisms (19 papers), Computational Drug Discovery Methods (17 papers), Metabolomics and Mass Spectrometry Studies (14 papers) and Eicosanoids and Hypertension Pharmacology (14 papers). The work is most often cited by research in Pharmacology (1.9k citations), Pharmacology (1.4k citations) and Oncology (2.2k citations). Yoshiro Saito has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Jun‐ichi Sawada, Shogo Ozawa, Nahoko Kaniwa, Keiko Maekawa, Kouichi Kurose, Kimie Sai, Emiko Sugiyama, Mayumi Saeki, Ryuichi Hasegawa and Masahiro Tohkin. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact